ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2022

November 10-14, 2022. Philadelphia, PA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1433
    A 48-week Analysis of a Pan-EU Real-world Study of SB5 Biosimilar Following Transition from Reference Adalimumab in Patients with Rheumatoid Arthritis, Axial Spondyloarthritis or Psoriatic Arthritis
  • Abstract Number: 0139
    A Clinical Study Designed to Support a Demonstration of Interchangeability Between AVT02 and Reference Adalimumab (Humira®)
  • Abstract Number: 1316
    A Cluster of Paget Disease of the Bone in Black or African American Patients in a Veteran Population
  • Abstract Number: 1853
    A Comparitive Study of NLRP3- and NLRP12-autoinflammatory Disease
  • Abstract Number: 1687
    A Core Inflammation Program Conserved Across Human and Murine Neutrophils
  • Abstract Number: 0856
    A Cross-Sectional Description of Physical Activity (PA) in Children with Juvenile Idiopathic Arthritis (JIA): The LEAP Study (Linking Exercise, Activity, and Pathophysiology in Canadian Children with Arthritis)
  • Abstract Number: 1936
    A De Novo Dominant-negative PSMB8 mutation is Linked to a More Severe CANDLE-like Phenotype
  • Abstract Number: 2158
    A Decade of Caring for SSc Patients: Do Outcomes Improve? Data from the Leiden CCISS Cohort
  • Abstract Number: 1051
    A Deep Neural Network Classifier to Identify Intrinsic Molecular Subsets of Systemic Sclerosis Using Histological Images
  • Abstract Number: 1822
    A Double-Blind, Placebo-Controlled, Ascending Dose Phase 2a Study of ABP-671, a Novel, Potent and Selective URAT1 Inhibitor, in Patients with Gout or Hyperuricemia
  • Abstract Number: 1678
    A Genome-Wide Association Analysis of 2,622,830 Individuals Reveals New Pathogenic Pathways in Gout
  • Abstract Number: 1454
    A High Genetic Risk of SLE Is Associated with an Increased Risk of Myocardial Infarction; A Combined Observational and Mendelian Randomization Study
  • Abstract Number: 0498
    A Longitudinal Assessment of Citrulline-specific CD4 T Cells in CCP+ at Risk Subjects and Patients with New-onset Rheumatoid Arthritis
  • Abstract Number: 1256
    A Machine Learning Pipeline for Prediction of Bone Marrow Oedema Along the Sacroiliac Joints on Magnetic Resonance Imaging
  • Abstract Number: PP09
    A Matter of Life and Death: Why Diversity, Equity and Inclusion Matter for Health Care Providers
  • Abstract Number: 1858
    A Multi-center Clinical Cohort Study of Chinese Anti-synthetase Syndrome Patients
  • Abstract Number: 2083
    A Network Meta-analysis on 532 SLE Patients: Low Complement Levels in the First Trimester Predict Disease Flare in Pregnancy
  • Abstract Number: 0593
    A New Cytokine Interleukin 40 Is Elevated in the Serum of Patients with Early Rheumatoid Arthritis and Associates with Autoantibodies and Neutrophil Activation
  • Abstract Number: 1149
    A Novel Mitochondrial Variant as a Predictor for the Rapid Progressive Knee Osteoarthritis Phenotype: Development of a Predictive Model and Functional Studies
  • Abstract Number: 2168
    A Novel Pharmaco-Interventional Approach for the Treatment of Refractory Digital Ischemia in Systemic Sclerosis – Percutaneous Revascularization Combined with Intravenous Vasodilatory Therapy
  • Abstract Number: 1047
    A Novel Prediction Tool for Progression of Systemic Sclerosis-Interstitial Lung Disease Despite Treatment with Immunosuppression
  • Abstract Number: 1152
    A Novel Serological Biomarker Measuring a Fragment of Cartilage Intermediate Layer Protein 1 Is Highly Upregulated in Rheumatic Diseases
  • Abstract Number: 1297
    A Paediatric-Adult Provider Dyad Care Model Improves Transition from Paediatric to Adult Health Care for Youth with Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: L03
    A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
  • Abstract Number: 1894
    A Phase 2, 104-Week Study of Repeat Lorecivivint Injections Evaluating Safety, Efficacy, and Bone Health Utilizing Quantitative Computed Tomography (qCT) in Knee Osteoarthritis (OA-06)
  • Abstract Number: 0371
    A Phase 2, Double-blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101/Lenabasum in Systemic Lupus Erythematosus, an Autoimmunity Centers of Excellence Study (ALE09)
  • Abstract Number: 2008
    A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Mechanistic Insight and Dosage Optimization Study of the Efficacy and Safety of Dazodalibep (VIB4920/HZN4920) in Patients with Rheumatoid Arthritis Having Inadequate Response to Conventional/Biological DMARDs
  • Abstract Number: 1899
    A Phase 3, 28-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (OA-10) to Evaluate the Efficacy and Safety of a Single Injection of Lorecivivint Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
  • Abstract Number: 1639
    A Phase 3, 56-Week, Multicenter, Randomized, Double-Blind, Placebo Controlled Trial (OA-11) to Evaluate the Efficacy and Safety of a Single Injection of Lorecivivint Injected in the Target Knee Joint of Moderate to Severe Osteoarthritis Participants
  • Abstract Number: 0752
    A Phase I Clinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Immunogenicity of Ebdarokimab in Patients with Moderate to Severe Plaque Psoriasis
  • Abstract Number: 0628
    A Positive-feedback Model for the Contribution of Virus-Specific T Cells to the Development of Rheumatoid Arthritis
  • Abstract Number: 1684
    A Potent Inhibitor of PAD4 Suppresses Histone Citrullination in Vitro and in Vivo
  • Abstract Number: 1897
    A Preliminary Estimate of Objectively Measured Sedentary Behavior in Knee Osteoarthritis
  • Abstract Number: 0479
    A Prospective Study Evaluating the Utility of Ultrasound in Monitoring Newly-Diagnosed GCA
  • Abstract Number: 2082
    A Prospective Study on Long-Term Clinical Outcomes of Patients with Lupus Nephritis Treated with an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
  • Abstract Number: 1350
    A Prospective Study on Pain Associated with Injection of Needles: PAIN Study
  • Abstract Number: 0987
    A Randomized Placebo-Controlled Phase 1 Study in Healthy Adult Volunteers of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN-303, a Potent Dual BAFF/APRIL Antagonist for the Treatment of Systemic Lupus Erythematosus and Other Autoantibody-Associated Diseases
  • Abstract Number: 0524
    A Randomized, Double-Blind, Phase II Study of Glucocorticoid Replacement by Vilobelimab, an Anti-C5a Monoclonal Antibody, in ANCA-Associated Vasculitis
  • Abstract Number: 0998
    A Real-world Analysis Showing Significant Variance in Treatment Patterns Among over 1,000 Systemic Lupus Erythematosus (SLE) Patients in the US
  • Abstract Number: 1917
    A Remote Behaviorally-Designed Intervention to Promote Physical Activity in Patients with Knee Osteoarthritis: Results of a Pilot Randomized Clinical Trial
  • Abstract Number: 1248
    A Retrospective Chart Review Examining How a Change in MRI Protocol Could Affect the Diagnosis of Axial Spondyloarthritis
  • Abstract Number: 1708
    A Role for the RAGE Receptor in Chronic Neurotoxicity After Exposure to SLE Antibodies That Cross React with dsDNA and the NMDA Receptor
  • Abstract Number: 0670
    A Short Allelic Epitope Coded by HLA-DRB1*03:01 Activates a Systemic Lupus Erythematosus Cell Aberration Cascade
  • Abstract Number: 0311
    A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Zunsemetinib, an Investigational Oral MK2 Inhibitor, at 80 Mg and 120 Mg Twice Daily Dose Levels in Healthy Subjects
  • Abstract Number: 0194
    A Survey of Patients with Ehlers Danlos Syndrome and Their Interest in Multidisciplinary Care
  • Abstract Number: 1777
    A Symptom Checker App Is Better at Classifying Inflammatory Disease Than Physicians Who Are Presented Identical Information
  • Abstract Number: 0457
    A Systematic Literature Review Informing the 2022 Update of the EULAR Recommendations for the Management of ANCA-associated Vasculitis
  • Abstract Number: 0487
    A Systematic Literature Review to Generate Descriptors for the Development of New Response Criteria in Giant Cell Arteritis
  • Abstract Number: 1240
    A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy for the Diagnosis of Cardiac Sarcoidosis
  • Abstract Number: 0106
    A Systematic Review of Racial and Ethnic Disparities in Disease Related Outcomes Among Patients with SLE
  • Abstract Number: 0142
    A Systemic Autoinflammatory Syndrome Caused by NEMO Exon 5 Skipping
  • Abstract Number: 0874
    A Tale of Many Canadas: Associations of Ethnicity with Juvenile Idiopathic Arthritis Categories and Disease Severity at Presentation in a Multicultural Universal Healthcare Setting: Results from ReACCh-Out
  • Abstract Number: 0225
    A Transitions Retreat: Preparing Rheumatology Fellows for Career Planning and the Scholarly Phase of Training
  • Abstract Number: 0878
    A United States Nationwide Analysis of Total Knee Arthroplasty in Patients < 21 Years Old
  • Abstract Number: 0218
    A Web-based Education Program Improves Health Care Provider Knowledge for the Care of Cancer Patients Receiving Immunotherapy Who Develop Rheumatic Immune-related Complications, and Those with Pre-existing Rheumatic Disease: An Initiative of CanRIO
  • Abstract Number: 1095
    A20(Tnfaip3) in Keratinocytes Restricts an Early Antiviral Gene Program Associated with Psoriatic Skin and Joint Disease
  • Abstract Number: 1370
    Abatacept in the Treatment of Refractory Juvenile Dermatomyositis
  • Abstract Number: 0530
    Abatacept Significantly Reduces Subclinical Inflammation During Treatment (6 Months), This Persists After Discontinuation (12 Months), Resulting in a Delay in the Clinical Development of RA in Patients at Risk of RA (The ARIAA Study)
  • Abstract Number: 0397
    Aberrant Global DNA Methylation in Peripheral Blood Cell Subpopulations of Patients with Axial Spondyloarthritis
  • Abstract Number: 1108
    Abnormal Baseline Chest CT Shows Increased Risk for Immune Checkpoint Inhibitor Associated Pneumonitis
  • Abstract Number: 2044
    Abnormalities of Extracellular Matrix Modeling Gene Expression in Salivary Gland Epithelial Cells of Patients with Sjögren’s Syndrome
  • Abstract Number: 2226
    Accelerated Aging Based on Blood DNA Methylation in SLE Participants Compared to Healthy Controls
  • Abstract Number: 0932
    Accelerated Waning of Protective Immunity After SARS-CoV-2 mRNA Vaccination in Patients Treated with Biological and Targeted Synthetic Disease Modifying Antirheumatic Drugs
  • Abstract Number: 0057
    Accelerating AxSpA Diagnosis: Exploring At-home Self-sampling, Symptom Checkers, Medical Student-visits and Asynchronous Report-based Assessment
  • Abstract Number: 0195
    Acceptance of Virtual Reality for Managing Their Disease Among People with Rheumatologic Conditions with and Without Prior Experience Using Virtual Reality
  • Abstract Number: 0751
    Accessing Telehealth and In-Person Healthcare During the COVID-19 Pandemic: Experiences of Individuals with Rheumatoid Arthritis
  • Abstract Number: 0707
    Accuracy of Administrative Claims Prescription Fill Data to Estimate Glucocorticoid Use and Dose in Patients with Rheumatoid Arthritis
  • Abstract Number: 1267
    Accuracy of Financial Disclosures in American-Based Rheumatology Journals
  • Abstract Number: 0167
    Accuracy of Multi-Centric Local Determination of Anti-Synthetase Autoantibodies in Patients with Anti-Synthetase Syndrome and Other Autoimmune Diseases
  • Abstract Number: 0700
    Accurate Identification of ANCA-Associated Vasculitis Cases from Clinical Notes Using Machine Learning
  • Abstract Number: 1597
    Achievement of Different Treatment Targets with Izokibep Demonstrates Efficacy Benefits in Patients with Active Psoriatic Arthritis: Results from a 16-Week Randomized, Placebo-Controlled Phase 2 Clinical Trial
  • Abstract Number: 2118
    Achieving Increasingly Stringent Clinical Disease Control Criteria Is Associated with Greater Improvements in Patient-Centric Measures of Physical Function and Pain in Patients with Active PsA: 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies
  • Abstract Number: 0410
    Achieving Increasingly Stringent Clinical Response Criteria & Lower Levels of Disease Activity Is Associated with Greater Improvements in Physical Function & HRQoL in Patients with Active Axial Spondyloarthritis: 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies
  • Abstract Number: 2088
    Achieving Systemic Lupus Erythematosus Disease Control or Low Lupus Disease Activity State Is Associated with Lower Rates of Organ Damage: Results from the Hopkins Lupus Cohort
  • Abstract Number: 1914
    Acoustic Classification of Early and Advanced Osteoarthritis of the Knee in Clinical Settings
  • Abstract Number: 0572
    ACR Workgroup to Develop Recommendations for PRO Use in Clinical Care for SLE
  • Abstract Number: 2227
    Active Takayasu Arteritis Is Associated with Plasma and Cellular Measures of Endothelial Dysfunction
  • Abstract Number: 1429
    Acute Cardiovascular Events Risk in Rheumatoid Arthritis Patients Treated with Tofacitinib or TNF Inhibitors, a Nationwide Cohort Study: RELATION Study
  • Abstract Number: 1817
    Acute Coronary Syndrome in Calcium Pyrophosphate Deposition Disease Patients: A Cross-sectional Study from the National Inpatient Sample
  • Abstract Number: 0773
    Additional Dose of SARS-CoV-2 Vaccine Improves Cross-Variant Neutralization Titers in Immunosuppressed Patients with Chronic Inflammatory Disease
  • Abstract Number: 0114
    Addressing Healthcare Disparities Through Implementation of a Medical Student-Based Patient Navigator Program
  • Abstract Number: 0033
    Adenosine A2A Receptor Signaling Enhances Expression of an Endogenous p53 Mouse Variant in Bone Marrow Mesenchymal Stem Cells
  • Abstract Number: 1358
    Adherence to Early DMARD Strategies in Newly Diagnosed RA Patients Seen in Routine Care: Results from the Canadian Early Arthritis Cohort Study
  • Abstract Number: 0829
    Adult Onset Still’s Disease: A Retrospective Study of Objective Manifestations and Outcomes
  • Abstract Number: 1937
    Adult Rheumatologists’ Knowledge, Comfort Level, and Perceived Barriers in Supporting Newly Transitioned Youth with Chronic Rheumatic Diseases in Canada
  • Abstract Number: 0454
    Advantages and Disadvantages in Applying 2022 ACR/EULAR Classification Criteria to Conventionally Diagnosed Japanese GPA Patients
  • Abstract Number: 0128
    Advantages of Alternate-Day Glucocorticoid Treatment Strategy for IgG4-Related Disease: A Preliminary Retrospective Study ID: 1287015
  • Abstract Number: 1365
    Adverse Events Associated with Belimumab Use in Pediatric Patients: Review and Analyses of the FDA Adverse Event Reporting System Database
  • Abstract Number: 1756
    Adverse Events in Patients with Inflammatory Joint Diseases: Results from the EULAR Coronavirus Vaccine (COVAX) Physician-reported Registry
  • Abstract Number: 1663
    Age-Dependent Expansion and Activation of Disease-Associated Microglia in Neuropsychiatric Symptoms of Systemic Lupus Erythematosus
  • Abstract Number: 2046
    Agreement Between Labial Biopsy and the OMERACT Grey-scale Ultrasound Scoring System for Salivary Glands in a Single-center Cohort of Patients with Suspected Sjögren’s Syndrome
  • Abstract Number: 2262
    Albumin-hitchhiking MMP13 siRNA Conjugate (siMMP13< (EG18L)2) for the Treatment of Rheumatic Disease
  • Abstract Number: 1896
    Alkylresorcinol, a Biomarker for Whole Grain Intake, and Its Association with Osteoarthritis: The MOST Study
  • Abstract Number: 0448
    All-Cause and Cause-Specific Mortality in ANCA-Associated Vasculitis: A Population-based Study
  • Abstract Number: 0467
    All-Cause and Cause-Specific Mortality in Giant Cell Arteritis, a Population-based Study
  • Abstract Number: 2068
    All-Cause Mortality in a Systemic Lupus Erythematosus Cohort
  • Abstract Number: 1582
    Allopurinol Use and Risk of Acute Coronary Syndrome in Patients with Incident Gout: A Population-based Study in Sweden
  • Abstract Number: 0922
    Alteration of the Cardiometabolic and Cardiovascular Proteome in Rheumatoid Arthritis. Modulation by Methotrexate and Tofacitinib
  • Abstract Number: 0180
    Alterations of Nutritional Status in Patients with Idiopathic Inflammatory Myopathies and Their Association with Disease-related Features
  • Abstract Number: 2161
    Alterations of Nutritional Status of Scleroderma Patients and Associations with Disease-specific Features
  • Abstract Number: 0621
    Altered Immunological Circadian Rhythms and the Effect of Treatment with Glucocorticoids on Circadian Rhythms of Immune Cells in Patients with Rheumatoid Arthritis: Bring Back the Rhythm
  • Abstract Number: 0604
    Altered Metabolic State in Myeloid Precursors and Mature Cells Within Rheumatoid Arthritis
  • Abstract Number: 0598
    An Arthritogenic Strain of Subdoligranulum Specifically Detectable in the Feces of Individuals At-risk for and with Rheumatoid Arthritis Is Bound by ACPA and Stimulates Th17 Cell Activation in Those with Rheumatoid Arthritis
  • Abstract Number: 1606
    An Expanded Anti-citrullinated Protein Antibody Profile Derived Using Unsupervised Machine Learning Predicts Treatment Responses to Biologic Therapies in Rheumatoid Arthritis
  • Abstract Number: 0543
    An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis
  • Abstract Number: 2154
    An Exploratory Phosphoproteomic and Immunohistochemical Analysis of Receptor Tyrosine Kinases and Downstream Signaling Pathways in Systemic Sclerosis Skin
  • Abstract Number: 1204
    An Increased Risk of Heart Failure and Heart Failure-Related Death Persists in Rheumatoid Arthritis: A National, Matched Cohort Study from 2000 to 2019
  • Abstract Number: 1102
    An Online Program for Primary Care Practitioners Enhances Confidence in the Ability to Care for Patients with or at Risk of Painful Knee Osteoarthritis
  • Abstract Number: 0273
    An Update on the Integrated Safety Analysis of Filgotinib in Patients with Moderately to Severely Active RA
  • Abstract Number: 1278
    ANA Testing Practices in the United States: A Population-Based Study Between 2000 and 2019
  • Abstract Number: 0683
    ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients Without Other Systemic Autoimmune Diseases: Clinical and Serological Characteristics, Results from the APS ACTION Clinical Database and Repository
  • Abstract Number: 1073
    Analysis of Clinical Outcomes in ANCA-associated Vasculitis Treated with Rituximab: Eighty Years a Single Center Experience in Japan
  • Abstract Number: 2098
    Analysis of Cutaneous Lupus Hospitalizations: A United States National Population-based Study
  • Abstract Number: 0490
    Analysis of Emergency Department Visits by Patients with Giant Cell Arteritis: A National Population-based Study
  • Abstract Number: 0810
    Analysis of Factors Associated with Good Therapeutic Response to Immunosuppressive Drugs in Patients with Non-infectious Uveitis: A Survival Analysis
  • Abstract Number: 1926
    Analysis of New Patient Referrals to a Large Pediatric Rheumatology Clinic
  • Abstract Number: 0682
    Analysis of Recurrent Thrombotic Events in a Large Single-center Primary Antiphospholipid Syndrome Cohort: Results from APS-Rio Cohort After over Than 600 Patients-year of Follow-up
  • Abstract Number: 2148
    Analysis of Serum Proteomics Data Identifies Beta-Defensin 2 as a Predictive Biomarker of Clinical Response to IL-17 Blockade in Psoriatic Arthritis
  • Abstract Number: 1879
    Analysis of the Association Between the Atrophic Factors Tripartite Motif Containing (TRIM) 63 and Atrogin-1 and the Clinical and Inflammatory Features of Patients with Idiopathic Inflammatory Myopathies
  • Abstract Number: 0383
    Analysis of the Performance of an Artificial Intelligence Algorithm for the Detection of Radiographic Sacroiliitis in an Independent Cohort of axSpA Patients Including Both Nr-axSpA and r-axSpA
  • Abstract Number: 1067
    Analysis of the Transcriptomic Profiles of Rheumatic Skin Diseases Reveals Disease-specific Endotypes
  • Abstract Number: 1093
    ANCA Associated Vasculitis: Online CME Improves Rheumatologists’ Knowledge and Confidence
  • Abstract Number: 1076
    ANCA-Associated Vasculitis Treated with Avacopan versus a Standard Prednisone Taper: Glucocorticoid Toxicity Index Scores by Domain
  • Abstract Number: 1133
    Ancestry, ACKR1, and Leucopenia in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1786
    Anterior Knee Pain Is Associated with 2-year Compartment Specific Patellofemoral Cartilage Worsening: The MOST Study
  • Abstract Number: 1032
    Anti-arthritogenic Effect of Smoking in Curdlan-Administered SKG Mice
  • Abstract Number: 0331
    Anti-dsDNA Antibodies by Multiplex Flow Immunoassay and Critihidia Luciliae Assays in NYU Lupus Registry: Discordance, Association with Nephritis, and Disease Flare Predictive Value
  • Abstract Number: 0663
    Anti-Erythrocyte Antibodies in Childhood Onset Systemic Lupus Erythematosus
  • Abstract Number: 2269
    Anti-NET Antibodies in Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
  • Abstract Number: 1476
    Anti-Neutrophil Extracellular Traps (NET) Antibodies and Their Association with Disease Activity and Clinical Phenotypes in Systemic Lupus Erythematosus
  • Abstract Number: 0832
    Anti-NOR 90 Antibodies: What Is the Clinical Significance in Rheumatic Inflammatory Conditions?
  • Abstract Number: 0035
    Anti-Peroxiredoxin 6 and Anti- Myosin Light Polypeptide 6 Autoantibodies with Interstitial Lung Disease and Severe Disease in Juvenile Dermatomyositis
  • Abstract Number: 2003
    Anti-rheumatic Treatment Modulates Expression of the Glycolytic Enzyme PFKFB3 in CD14+ Monocytes of Patients with Rheumatoid Arthritis, Which Contributes to Dissimilarities of the IFN Signature
  • Abstract Number: 1523
    Anti-RNPC3 Autoantibodies in Mixed Connective Tissue Disease Are Associated with Systemic Sclerosis Skin Involvement
  • Abstract Number: 1983
    Anti-S1 Antibody Levels Two Weeks After the Second Dose of an mRNA anti-SARS-CoV2 Vaccine Predict Maintenance of a Potent Neutralizing Activity over 24 Weeks in RA Patients
  • Abstract Number: 0154
    Anti-SMN Autoantibodies in Mixed Connective Tissue Disease Are Associated with a Scleromyositis Phenotype
  • Abstract Number: 0164
    Anti-SSa/SSb and Ro52 Status and Pulmonary Function Tests in Patients with Interstitial Lung Disease and Idiopathic Inflammatory Myopathies
  • Abstract Number: 1564
    Anti-TNF versus Anti-IL6 Receptor Antagonist Therapy in Severe Ocular Involvement in Behçet’s Disease
  • Abstract Number: 1068
    Anti-vinculin Antibodies in Systemic Sclerosis: Associations with Slow Gastric Transit and Extra-Intestinal Clinical Phenotype
  • Abstract Number: 0686
    Anti-β2GP1/HLA-DR Antibody Is Associated with Arterial Thrombosis in Female Patients with Connective Tissue Diseases: A Cross-Sectional Study in Japan
  • Abstract Number: 0688
    Antibodies of the IgA Isotype Target Neutrophil Extracellular Traps in APS
  • Abstract Number: 0800
    Antibody Response to Shingrix Vaccination in Patients with Rheumatoid Arthritis, Seronegative Spondyloarthropathy and Systemic Lupus Erythematosus on Immunosuppressive Medications
  • Abstract Number: 1893
    Antihistamine Use and Structural Progression of Knee OA: A Post-Hoc Analysis of Two Phase 3 Clinical Trials
  • Abstract Number: 0681
    Antiphospholipid Antibodies and Incident Cardiovascular Events in a Diverse Population: Results from the Dallas Heart Study
  • Abstract Number: 1468
    Apathy Measurement in a Cohort of Systemic Lupus Erythematosus
  • Abstract Number: 1839
    Appendicitis Still a Challenge for FMF Patients?
  • Abstract Number: 0456
    Application of Adult ACR/EULAR 2022 Classification Criteria in Pediatric Vasculitis Patients
  • Abstract Number: 0732
    Application of Natural Language Processing to Identify Varicella Zoster Infection in Clinical Notes
  • Abstract Number: 1272
    Application of the Consolidated Framework for Implementation Research (CFIR) to Study Top-Performing Practices in the RISE Registry
  • Abstract Number: 2130
    Apremilast in Bio-Naïve Patients with Early Psoriatic Arthritis: A National, Real-Life, Multicenter, Non-Interventional, Prospective, 52-week Cohort Study
  • Abstract Number: 0697
    Are Fibromyalgia and Depression as Common as Any Primary Diagnosis in Routine Rheumatology Care, Albeit as Secondary Diagnoses, but Which May Confound Clinical Assessment?
  • Abstract Number: 1610
    Are Serological Protease-mediated Peptides of Tissue Remodeling and Inflammation the New Disease Activity Biomarkers in Psoriatic Arthritis Patients?
  • Abstract Number: 1287
    Are the American College of Rheumatology’s Web-Based Patient Education Materials Easy for Patients to Read and Comprehend?
  • Abstract Number: 0406
    Are the BASDAI & BASFI Capturing the Full Impact of Disease Activity on Quality of Life in Women with Axial Spondyloarthritis?
  • Abstract Number: 0322
    Are Virtual Cognitive Assessments Comparable to In-person Assessments in a Systemic Lupus Erythematosus Cohort?
  • Abstract Number: 0228
    Are We Choosing Wisely? Results of a Survey of Internal Medicine Residents in a Single Center
  • Abstract Number: 0393
    Are We Meeting Patients’ Treatment Goals with Guideline-Based Therapy for Psoriatic Arthritis?
  • Abstract Number: 1023
    Are We Treating-to-target in Spondyloarthritis (SpA)? A Cross Sectional Analysis from the Asia Pacific League of Associations for Rheumatology (APLAR) SpA Registry
  • Abstract Number: 1863
    Aromatase Inhibitor Induced Musculoskeletal Inflammation Is Observed Independent of Oophorectomy in a Novel Mouse Model
  • Abstract Number: 1699
    Arthritis-associated Synovial CD64-Ly6c- myeloid Cells Comprise 2 Subpopulations
  • Abstract Number: 1990
    Artificial Intelligence Applied to Transcriptomics Profiling of Synovial Tissue Biopsies Accurately Predicts Rheumatoid Arthritis Patients Who Will Respond or Be Refractory to Standard Biological Treatments
  • Abstract Number: 1335
    Artificial Intelligence–enabled Sentiment Analysis of Public Attitude Toward Pregnancy in Lupus Social Media Group
  • Abstract Number: 0399
    ASAS Recommendations for Requesting and Reporting Imaging in Patients with Suspected Axial Spondyloarthritis
  • Abstract Number: 0542
    ASAS-EULAR Recommendations for the Management of Axial Spondyloarthritis: 2022 Update
  • Abstract Number: 0973
    Assessing Musculoskeletal Health Needs of Underserved Patients & Community Members Using a Community Based Participatory Research Approach
  • Abstract Number: 0959
    Assessing the Association Between Hydroxychloroquine and Preeclampsia Risk in SLE Pregnancies Using Administrative Claims Data
  • Abstract Number: 1515
    Assessing the Difference Between Radiographic Axial Spondylorthritis and Non-radiographic Axial Spondylorthritis in a Two-center Descriptive Study with Mexican Patients: The Influence of Clinical, Demographic, Laboratory and Clinimetric Features
  • Abstract Number: 1257
    Assessing the Effectiveness of Tocilizumab in Giant Cell Arteritis by PET: Multicenter Study of 101 Patients of Clinical Practice
  • Abstract Number: 0485
    Assessing the Effectiveness of Tocilizumab in Newly Diagnosed Giant Cell Arteritis versus Refractory/recurrent Giant Cell Arteritis in Clinical Practice
  • Abstract Number: 1930
    Assessing the Number of Children Evaluated for Recurrent Fevers During the COVID-19 Pandemic in North America
  • Abstract Number: 1808
    Assessing the Role of the NLRP3 Inflammasome in Driving Inflammation in Affected Joints of Patients with Inter-critical Gout
  • Abstract Number: 0330
    Assessing the Utility of the Montreal Cognitive Assessment as a Screening Tool for Cognitive Impairment in Patients with SLE Using a Bayesian Item-Response Theory Model
  • Abstract Number: 1816
    Assessing Urate Deposition and Inflammation in the Vasculature of Gout Patients Using Dual Energy Computed Tomography and Positron Emission Tomography Pre and Post Pegloticase- a Pilot Study
  • Abstract Number: 0966
    Assessment and Application of Royal College of Obstetricians and Gynaecologists (RCOG) Risk Scores in the Prevention of Venous Thromboembolism Peri- and Postpartum in Systemic Lupus Erythematosus
  • Abstract Number: 0223
    Assessment During Rheumatology Fellowship After the Reforms in the French National Medical Curriculum: Has Anything Changed?
  • Abstract Number: 1875
    Assessment of Antibody Levels to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) in Patients with Idiopathic Inflammatory Myopathies Receiving Treatment with Intravenous Immunoglobulin
  • Abstract Number: 1063
    Assessment of Calcinosis in Portuguese Patients with Systemic Sclerosis – a Multicenter Study
  • Abstract Number: 1237
    Assessment of Common Femoral Vein Intima-Media Thickness by Ultrasound in Behçet’s Disease: Comparative Study of Patients with or Without Vascular Involvement in a National Referral Center
  • Abstract Number: 1502
    Assessment of Perceptions and Practices Regarding the Collaborative Management of Patients with Psoriatic Arthritis Among US Dermatology and Rheumatology Teams
  • Abstract Number: 0466
    Assessment of Probability Scores to Predict Giant Cell Arteritis
  • Abstract Number: 1302
    Assessment of the Transition of Care from Pediatric to Adult Rheumatology in a Tertiary Center
  • Abstract Number: 2116
    Assessment of the Ultrasound and Clinical Response to Apremilast Using a Joint-periarticular-nail Ultrasound Index and Clinical Evaluation in Patients with Active Psoriatic Arthritis
  • Abstract Number: 1973
    Association Between Activity Limitations, Sleep Disturbance, Pain Sensitivity, Pain Intensity, and Widespread Pain in Adults with Rheumatoid Arthritis
  • Abstract Number: 1658
    Association Between Anti-Sjögren Syndrome/Scleroderma Autoantigen 1 (SSSCA1) Antibodies and Cancer in Systemic Sclerosis
  • Abstract Number: 1750
    Association Between Appendicitis and the Risk of Systemic Lupus Erythematosus: A Population-based, Case-control Study
  • Abstract Number: 0885
    Association Between Changes in Inflammatory Pathways Associated with a Reduction in CV Risk: Results from the LiiRA Study
  • Abstract Number: 0345
    Association Between Cumulated Hydroxychloroquine in Systemic Lupus Erythematosus and Development of Cardiac Conduction Alterations: A Multiple Logistic Regression Analysis
  • Abstract Number: 1206
    Association Between Different Alcoholic Beverages and Serum Urate Level: A Cross-Sectional Study Using Large Medical Checkup Data
  • Abstract Number: 1921
    Association Between Knee Osteoarthritis and Health-Related Quality of Life in Persons with Type 2 Diabetes
  • Abstract Number: 0706
    Association Between Metabolic Syndrome and Knee Pain over 10-13 Years in Middle-Aged Adults
  • Abstract Number: 0287
    Association Between Short-Term Response to Upadacitinib Treatment and Long-Term Clinical Outcomes in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy
  • Abstract Number: 1019
    Association Between Stringent Clinical Measures of Disease Activity and Clinically Meaningful Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: Results from KEEPsAKE 1 and 2 Clinical Trials
  • Abstract Number: 1895
    Association Between Synovial Tissue Metabolomic Profile and Pain in Patients with Knee Osteoarthritis
  • Abstract Number: 0034
    Association of Anti-Tropomyosin Alpha-4 Autoantibodies with Cutaneous Manifestations in Juvenile Dermatomyositis
  • Abstract Number: 0091
    Association of Area-Level Heat and Social Vulnerability with Recurrent Hospitalizations Among Individuals with Rheumatic Conditions
  • Abstract Number: 1754
    Association of Cognitive Impairment and Symptomatic Lower Extremity Osteoarthritis by Level of Physical Activity: Preliminary Data from the Johnston County Health Study
  • Abstract Number: 1637
    Association of Dermatomyositis with Cardiovascular Disease: A Case-Control Study in the All of Us Research Program
  • Abstract Number: 0680
    Association of Environmental Risk Factors with Antiphospholipid Antibodies and Thrombosis in 1199 International Patients Referred for Suspected Antiphospholipid Syndrome
  • Abstract Number: 1222
    Association of Fibromyalgia, PTSD and Combat Deployments in Active Duty Military
  • Abstract Number: 0847
    Association of Frontal Plane Trunk Motion During Gait with Abductor Strength, Fatigue, and Physical Activity in Women with Hip Osteoarthritis
  • Abstract Number: 0995
    Association of Glucocorticoid Use with Healthcare Utilization Among Persons with Systemic Lupus Erythematosus
  • Abstract Number: 0639
    Association of Gut Microbiome Streptococcus, Health Status, Cytokines, and HLA Class in Anti-Ro+ Mothers of Children with Neonatal Lupus: Insights into Progression of Clinical Autoimmunity
  • Abstract Number: 1826
    Association of High Uric Acid Levels with Low Bone Mineral Density in Pre- but Not Post-menopausal Women with Rheumatoid Arthritis
  • Abstract Number: 1379
    Association of HLA Alleles with Specific Auto-antibodies in an Ancestrally Diverse Population of Childhood Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 2059
    Association of Hydroxychloroquine with the Incidence of Infectious Disease in Systemic Lupus Erythematosus: Data from the LUNA Registry
  • Abstract Number: 2236
    Association of microRNA-30b Plasma Expression with Fibromyalgia Clinical Features and with Corneal Small Nerve Fiber Pathology
  • Abstract Number: 1479
    Association of Neuromyelitis Optica and Systemic Lupus Erythematosus: Analysis of National Inpatient Sample 
  • Abstract Number: 2097
    Association of Renal Biopsy NIH Activity and Chronicity Scores with Clinical Outcomes in a Cohort of Patients with Lupus Nephritis
  • Abstract Number: 1595
    Association of Sustained Lupus Low Disease Activity State with Improved Outcomes in SLE: A Multinational Prospective Cohort Study
  • Abstract Number: 2103
    Association of Telomere Length with Phenotypic Frailty in Adults with Systemic Lupus Erythematosus
  • Abstract Number: 0839
    Association of Tibial Acceleration During Walking to Knee Pain and Loading in Adults with Knee Osteoarthritis
  • Abstract Number: 1634
    Association of Ultra-processed Food Intake with Risk of Systemic Lupus Erythematosus in Women
  • Abstract Number: 0095
    Association of Urban vs. Rural Residence with New DMARD Initiation in US Veterans with Active Rheumatoid Arthritis
  • Abstract Number: 2202
    Association of Visit-based Retention and Receipt of Serologic Testing with Acute Care Use Among Young Adults with Lupus: A Medicare Cohort Study
  • Abstract Number: 1881
    Association Study Between anti-TIF1γ Antibody and Development of Neoplasia in Three Tertiary Hospitals
  • Abstract Number: 0656
    Association Study Identified HLA-DQA1 as a Genetic Risk of Systemic Lupus Erythematosus-associated Pulmonary Arterial Hypertension
  • Abstract Number: 0912
    Associations Between Fatty Acid Amide Hydrolase Variants and Response to Cannabis Use for Pain Management in Rheumatoid Arthritis
  • Abstract Number: 1912
    Associations of Nociceptive Dysfunction with Physical Activity in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
  • Abstract Number: 1055
    Associations of Potential Risk Factors with Severe Outcomes in Scleroderma Renal Crisis: Results from a Single Center Study
  • Abstract Number: 0027
    Associations of Serum C3f with Selected Biomarkers and Radiographic and Clinical Features of Knee Osteoarthritis
  • Abstract Number: 0893
    ATP-Binding Cassette G1 Membrane Transporter-mediated Cholesterol Efflux Capacity Influences Coronary Atherosclerosis and Cardiovascular Risk in RA
  • Abstract Number: 0359
    Attainment of Remission with Anifrolumab: A Post Hoc Analysis of Pooled TULIP-1 and TULIP-2 Datasets
  • Abstract Number: 1629
    AUR200: An Improved BAFF/APRIL Inhibitor with Increased Potency and Safety for the Treatment of B Cell-Mediated Diseases
  • Abstract Number: 1883
    Auto-antibodies Targeting Membrane Repair Proteins Enhances Myositis Phenotype
  • Abstract Number: 1965
    Autoantibodies Against a Specific 25-mer Peptide from P. Gingivalis Are Present in Sera of Patients with Rheumatoid Arthritis and Early Arthritis
  • Abstract Number: 1472
    Autoantibodies Against Tripartite-Motif 72 Protein (TRIM72) in Systemic Lupus Erythematosus Patients and in a Lupus Mouse Models with Myocarditis, Can Compromise Membrane Repair in Cardiomyocytes Potentially Contributing to Cardiovascular Disease Progression
  • Abstract Number: 2241
    Autoantibodies and Damage in Patients with Idiopathic Inflammatory Myopathies: A Longitudinal Multicenter Study from the EuroMyositis International Network
  • Abstract Number: 1874
    Autoantibodies Are Common in Patients with Idiopathic Interstitial Lung Disease Suggesting a High Prevalence of Undiagnosed Autoimmune Connective Tissue Disease
  • Abstract Number: 2167
    Autoantibodies in Patients with Early Systemic Sclerosis in the Collaborative National Quality and Efficacy Registry
  • Abstract Number: 0592
    Autoantibodies Targeting Malondialdehyde-modifications Are Potential Mediators of Inflammation and Bone Loss in RA, Acting via Macrophage and Osteoclast Regulatory Pathways
  • Abstract Number: 0333
    Autoantibody Trajectories Associate with Classification and Treatment Response in Lupus Nephritis
  • Abstract Number: 2265
    Autoimmune RNA Dysregulation and Seizures: Therapeutic Prospects in Neuropsychiatric Systemic Lupus Erythematosus
  • Abstract Number: 1201
    Autoimmune Serologies, Cell-Bound Complement Activation Products, and Autoimmune Rheumatic Disease Symptoms After COVID-19 Infection
  • Abstract Number: 1223
    Autoimmune Thyroid Disease Associates with Hand Pain in Older Adults in the Third National Health and Nutrition Examination Survey
  • Abstract Number: 2240
    Autoimmunity Against Melanoma Differentiation-Associated Protein 5 Advances Acute Lung Injury to Interstitial Lung Disease in Mice
  • Abstract Number: 0149
    Autoinflammatory Diseases Associated with NOD2 and Other Concurrent Genetic Mutations
  • Abstract Number: 0972
    Automated Joint Space Width Measurement for Hand Osteoarthritis: A Deep Learning Approach
  • Abstract Number: 1220
    Autonomic Dysfunction in Sjogren’s Disease
  • Abstract Number: 0793
    Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation
  • Abstract Number: 2020
    Autophagy-related Risk Loci in Systemic Lupus Erythematous and Sjögren’s Disease
  • Abstract Number: 1154
    Axial Spondyloarthritis: Profiling of MiRNAs in Peripheral Blood Mononuclear Cells
  • Abstract Number: 0958
    Azathioprine Metabolite Levels and Outcomes During Pregnancies in Women with Rheumatic Disease
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology